Hostname: page-component-76fb5796d-vvkck Total loading time: 0 Render date: 2024-04-26T21:13:37.248Z Has data issue: false hasContentIssue false
  • English
  • Français

Haloperidol in the Treatment of Stutterers

Published online by Cambridge University Press:  29 January 2018

P. T. Quinn  and
E. C. Peachey
P. T. Quinn
Affiliation:
Division of Communication Disorders, School of Psychiatry, University of New South Wales, Kensington, N.S.W. 2036, Australia
E. C. Peachey
Affiliation:
Division of Communication Disorders, School of Psychiatry, University of New South Wales, Kensington, N.S.W. 2036, Australia
Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Correspondence
Information
The British Journal of Psychiatry , Volume 123 , Issue 573 , August 1973 , pp. 247 - 248
Copyright
Copyright © Royal College of Psychiatrists, 1973

References

Connell, P. H., Corbett, J. A., Horne, D. J., and Mathews, A. M. (1967). ‘Drug treatment of adolescent tiqueurs’. British Journal of Psychiatry, 113, 375–81.CrossRefGoogle ScholarPubMed
Perkins, W. H. (1971). In Speech Pathology. C. V. Mosby Company, St. Louis, p. 320.Google Scholar
Tapia, F. (1969). ‘Haldol in the treatment of children with tics and stutterers—and an incidental finding’. Psychiatric Quarterly, 43, 647–49.CrossRefGoogle ScholarPubMed
Wells, P. G., and Malcolm, M. T. (1971). ‘Controlled trial of the treatment of 36 stutterers’.—British Journal of Psychiatry, 119, 603–4.CrossRefGoogle ScholarPubMed
Submit a response

eLetters

No eLetters have been published for this article.